Skip to main content
. 2022 May 23;7(10):e157053. doi: 10.1172/jci.insight.157053

Figure 1. Cardiopulmonary symptoms represented in study sample.

Figure 1

Bar plot of the number of participants who reported potentially cardiopulmonary symptoms in the 2 weeks prior to echocardiogram at a median of 7.2 months (IQR, 4.1–9.1 months) after COVID-19 onset (n = 102). The primary composite outcome is the presence of dyspnea, chest pain, or palpitations. These are not prevalence estimates within the population of those recovering from COVID-19, but are presented to provide context for the associations between echocardiographic findings, biomarkers, and symptoms reported here.